A new clinical trial has shown that the Cefaly migraine treatment device is safe and effective for migraine prevention, according to manufacturer Cefaly Technology.
Cefaly is an external trigeminal nerve stimulation device (e-TNS) that is magnetically connected to a self-adhesive electrode placed on the forehead. It sends micro-impulses through the electrode to the upper branch of the trigeminal nerve to either relieve or prevent a migraine headache. The “prevent” setting is intended for people who have three or more migraine attacks per month and need treatment to reduce the frequency of episodes, according to Seraing, Belgium-based Cefaly Technology, which has U.S. operations in Wilton, Conn.
Get the full story on our sister site, Medical Design & Outsourcing.